US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2023-11-01
|
| Series: | CPT: Pharmacometrics & Systems Pharmacology |
| Online Access: | https://doi.org/10.1002/psp4.13033 |
| _version_ | 1797449884463267840 |
|---|---|
| author | Stacy S. Shord Hao Zhu Jiang Liu Atiqur Rahman Brian Booth Issam Zineh |
| author_facet | Stacy S. Shord Hao Zhu Jiang Liu Atiqur Rahman Brian Booth Issam Zineh |
| author_sort | Stacy S. Shord |
| collection | DOAJ |
| first_indexed | 2024-03-09T14:32:28Z |
| format | Article |
| id | doaj.art-3403c3b027e44653962206bc7f1dfc91 |
| institution | Directory Open Access Journal |
| issn | 2163-8306 |
| language | English |
| last_indexed | 2024-03-09T14:32:28Z |
| publishDate | 2023-11-01 |
| publisher | Wiley |
| record_format | Article |
| series | CPT: Pharmacometrics & Systems Pharmacology |
| spelling | doaj.art-3403c3b027e44653962206bc7f1dfc912023-11-27T20:51:16ZengWileyCPT: Pharmacometrics & Systems Pharmacology2163-83062023-11-0112111573157610.1002/psp4.13033US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancerStacy S. Shord0Hao Zhu1Jiang Liu2Atiqur Rahman3Brian Booth4Issam Zineh5Division of Cancer Pharmacology II (DCPII), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER) US Food and Drug Administration (FDA) Silver Spring Maryland USADivision of Pharmacometrics (DPM), OCP, OTS, CDER FDA Silver Spring Maryland USADivision of Pharmacometrics (DPM), OCP, OTS, CDER FDA Silver Spring Maryland USADivision of Cancer Pharmacology II (DCPII), Office of Clinical Pharmacology (OCP), Office of Translational Sciences (OTS), Center for Drug Evaluation and Research (CDER) US Food and Drug Administration (FDA) Silver Spring Maryland USADivision of Cancer Pharmacology I (DCPI), OCP, OTS, CDER FDA Silver Spring Maryland USAOCP, OTS, CDER FDA Silver Spring Maryland USAhttps://doi.org/10.1002/psp4.13033 |
| spellingShingle | Stacy S. Shord Hao Zhu Jiang Liu Atiqur Rahman Brian Booth Issam Zineh US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer CPT: Pharmacometrics & Systems Pharmacology |
| title | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_full | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_fullStr | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_full_unstemmed | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_short | US Food and Drug Administration embraces using innovation to identify optimized dosages for patients with cancer |
| title_sort | us food and drug administration embraces using innovation to identify optimized dosages for patients with cancer |
| url | https://doi.org/10.1002/psp4.13033 |
| work_keys_str_mv | AT stacysshord usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT haozhu usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT jiangliu usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT atiqurrahman usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT brianbooth usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer AT issamzineh usfoodanddrugadministrationembracesusinginnovationtoidentifyoptimizeddosagesforpatientswithcancer |